Global and Japan Teriflunomide Market Size, Status and Forecast 2024-2031

Report ID: 1014708 | Published Date: Oct 2024 | No. of Page: 100 | Base Year: 2023 | Rating: 4 | Webstory: Check our Web story
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Teriflunomide Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Tablets
        1.2.3 Powder
    1.3 Market by Application
        1.3.1 Global Teriflunomide Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Immunosuppression
        1.3.3 Cancer Treatment
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Teriflunomide Market Perspective (2016-2027)
    2.2 Teriflunomide Growth Trends by Regions
        2.2.1 Teriflunomide Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Teriflunomide Historic Market Share by Regions (2016-2021)
        2.2.3 Teriflunomide Forecasted Market Size by Regions (2022-2027)
    2.3 Teriflunomide Industry Dynamic
        2.3.1 Teriflunomide Market Trends
        2.3.2 Teriflunomide Market Drivers
        2.3.3 Teriflunomide Market Challenges
        2.3.4 Teriflunomide Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Teriflunomide Players by Revenue
        3.1.1 Global Top Teriflunomide Players by Revenue (2016-2021)
        3.1.2 Global Teriflunomide Revenue Market Share by Players (2016-2021)
    3.2 Global Teriflunomide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Teriflunomide Revenue
    3.4 Global Teriflunomide Market Concentration Ratio
        3.4.1 Global Teriflunomide Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Teriflunomide Revenue in 2020
    3.5 Teriflunomide Key Players Head office and Area Served
    3.6 Key Players Teriflunomide Product Solution and Service
    3.7 Date of Enter into Teriflunomide Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Teriflunomide Breakdown Data by Type
    4.1 Global Teriflunomide Historic Market Size by Type (2016-2021)
    4.2 Global Teriflunomide Forecasted Market Size by Type (2022-2027)

5 Teriflunomide Breakdown Data by Application
    5.1 Global Teriflunomide Historic Market Size by Application (2016-2021)
    5.2 Global Teriflunomide Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Teriflunomide Market Size (2016-2027)
    6.2 North America Teriflunomide Market Size by Type
        6.2.1 North America Teriflunomide Market Size by Type (2016-2021)
        6.2.2 North America Teriflunomide Market Size by Type (2022-2027)
        6.2.3 North America Teriflunomide Market Size by Type (2016-2027)
    6.3 North America Teriflunomide Market Size by Application
        6.3.1 North America Teriflunomide Market Size by Application (2016-2021)
        6.3.2 North America Teriflunomide Market Size by Application (2022-2027)
        6.3.3 North America Teriflunomide Market Size by Application (2016-2027)
    6.4 North America Teriflunomide Market Size by Country
        6.4.1 North America Teriflunomide Market Size by Country (2016-2021)
        6.4.2 North America Teriflunomide Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Teriflunomide Market Size (2016-2027)
    7.2 Europe Teriflunomide Market Size by Type
        7.2.1 Europe Teriflunomide Market Size by Type (2016-2021)
        7.2.2 Europe Teriflunomide Market Size by Type (2022-2027)
        7.2.3 Europe Teriflunomide Market Size by Type (2016-2027)
    7.3 Europe Teriflunomide Market Size by Application
        7.3.1 Europe Teriflunomide Market Size by Application (2016-2021)
        7.3.2 Europe Teriflunomide Market Size by Application (2022-2027)
        7.3.3 Europe Teriflunomide Market Size by Application (2016-2027)
    7.4 Europe Teriflunomide Market Size by Country
        7.4.1 Europe Teriflunomide Market Size by Country (2016-2021)
        7.4.2 Europe Teriflunomide Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Teriflunomide Market Size (2016-2027)
    8.2 Asia-Pacific Teriflunomide Market Size by Type
        8.2.1 Asia-Pacific Teriflunomide Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Teriflunomide Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Teriflunomide Market Size by Type (2016-2027)
    8.3 Asia-Pacific Teriflunomide Market Size by Application
        8.3.1 Asia-Pacific Teriflunomide Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Teriflunomide Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Teriflunomide Market Size by Application (2016-2027)
    8.4 Asia-Pacific Teriflunomide Market Size by Region
        8.4.1 Asia-Pacific Teriflunomide Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Teriflunomide Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Teriflunomide Market Size (2016-2027)
    9.2 Latin America Teriflunomide Market Size by Type
        9.2.1 Latin America Teriflunomide Market Size by Type (2016-2021)
        9.2.2 Latin America Teriflunomide Market Size by Type (2022-2027)
        9.2.3 Latin America Teriflunomide Market Size by Type (2016-2027)
    9.3 Latin America Teriflunomide Market Size by Application
        9.3.1 Latin America Teriflunomide Market Size by Application (2016-2021)
        9.3.2 Latin America Teriflunomide Market Size by Application (2022-2027)
        9.3.3 Latin America Teriflunomide Market Size by Application (2016-2027)
    9.4 Latin America Teriflunomide Market Size by Country
        9.4.1 Latin America Teriflunomide Market Size by Country (2016-2021)
        9.4.2 Latin America Teriflunomide Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Teriflunomide Market Size (2016-2027)
    10.2 Middle East & Africa Teriflunomide Market Size by Type
        10.2.1 Middle East & Africa Teriflunomide Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Teriflunomide Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Teriflunomide Market Size by Type (2016-2027)
    10.3 Middle East & Africa Teriflunomide Market Size by Application
        10.3.1 Middle East & Africa Teriflunomide Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Teriflunomide Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Teriflunomide Market Size by Application (2016-2027)
    10.4 Middle East & Africa Teriflunomide Market Size by Country
        10.4.1 Middle East & Africa Teriflunomide Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Teriflunomide Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Sanofi Aventis
        11.1.1 Sanofi Aventis Company Details
        11.1.2 Sanofi Aventis Business Overview
        11.1.3 Sanofi Aventis Teriflunomide Introduction
        11.1.4 Sanofi Aventis Revenue in Teriflunomide Business (2016-2021)
        11.1.5 Sanofi Aventis Recent Development
    11.2 Genzyme Corporation
        11.2.1 Genzyme Corporation Company Details
        11.2.2 Genzyme Corporation Business Overview
        11.2.3 Genzyme Corporation Teriflunomide Introduction
        11.2.4 Genzyme Corporation Revenue in Teriflunomide Business (2016-2021)
        11.2.5 Genzyme Corporation Recent Development
    11.3 Amneal Pharmaceuticals NY LC
        11.3.1 Amneal Pharmaceuticals NY LC Company Details
        11.3.2 Amneal Pharmaceuticals NY LC Business Overview
        11.3.3 Amneal Pharmaceuticals NY LC Teriflunomide Introduction
        11.3.4 Amneal Pharmaceuticals NY LC Revenue in Teriflunomide Business (2016-2021)
        11.3.5 Amneal Pharmaceuticals NY LC Recent Development
    11.4 Glenmark Pharmaceuticals
        11.4.1 Glenmark Pharmaceuticals Company Details
        11.4.2 Glenmark Pharmaceuticals Business Overview
        11.4.3 Glenmark Pharmaceuticals Teriflunomide Introduction
        11.4.4 Glenmark Pharmaceuticals Revenue in Teriflunomide Business (2016-2021)
        11.4.5 Glenmark Pharmaceuticals Recent Development
    11.5 Msn Laboratories Private Limited
        11.5.1 Msn Laboratories Private Limited Company Details
        11.5.2 Msn Laboratories Private Limited Business Overview
        11.5.3 Msn Laboratories Private Limited Teriflunomide Introduction
        11.5.4 Msn Laboratories Private Limited Revenue in Teriflunomide Business (2016-2021)
        11.5.5 Msn Laboratories Private Limited Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Teriflunomide Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Tablets
    Table 3. Key Players of Powder
    Table 4. Global Teriflunomide Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Teriflunomide Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Teriflunomide Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Teriflunomide Market Share by Regions (2016-2021)
    Table 8. Global Teriflunomide Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Teriflunomide Market Share by Regions (2022-2027)
    Table 10. Teriflunomide Market Trends
    Table 11. Teriflunomide Market Drivers
    Table 12. Teriflunomide Market Challenges
    Table 13. Teriflunomide Market Restraints
    Table 14. Global Teriflunomide Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Teriflunomide Market Share by Players (2016-2021)
    Table 16. Global Top Teriflunomide Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Teriflunomide as of 2020)
    Table 17. Ranking of Global Top Teriflunomide Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Teriflunomide Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Teriflunomide Product Solution and Service
    Table 21. Date of Enter into Teriflunomide Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Teriflunomide Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Teriflunomide Revenue Market Share by Type (2016-2021)
    Table 25. Global Teriflunomide Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Teriflunomide Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Teriflunomide Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Teriflunomide Revenue Market Share by Application (2016-2021)
    Table 29. Global Teriflunomide Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Teriflunomide Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Teriflunomide Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Teriflunomide Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Teriflunomide Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Teriflunomide Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Teriflunomide Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Teriflunomide Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Teriflunomide Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Teriflunomide Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Teriflunomide Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Teriflunomide Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Teriflunomide Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Teriflunomide Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Teriflunomide Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Teriflunomide Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Teriflunomide Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Teriflunomide Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Teriflunomide Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Teriflunomide Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Teriflunomide Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Teriflunomide Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Teriflunomide Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Teriflunomide Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Teriflunomide Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Teriflunomide Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Teriflunomide Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Teriflunomide Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Teriflunomide Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Teriflunomide Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Teriflunomide Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Teriflunomide Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Sanofi Aventis Company Details
    Table 62. Sanofi Aventis Business Overview
    Table 63. Sanofi Aventis Teriflunomide Product
    Table 64. Sanofi Aventis Revenue in Teriflunomide Business (2016-2021) & (US$ Million)
    Table 65. Sanofi Aventis Recent Development
    Table 66. Genzyme Corporation Company Details
    Table 67. Genzyme Corporation Business Overview
    Table 68. Genzyme Corporation Teriflunomide Product
    Table 69. Genzyme Corporation Revenue in Teriflunomide Business (2016-2021) & (US$ Million)
    Table 70. Genzyme Corporation Recent Development
    Table 71. Amneal Pharmaceuticals NY LC Company Details
    Table 72. Amneal Pharmaceuticals NY LC Business Overview
    Table 73. Amneal Pharmaceuticals NY LC Teriflunomide Product
    Table 74. Amneal Pharmaceuticals NY LC Revenue in Teriflunomide Business (2016-2021) & (US$ Million)
    Table 75. Amneal Pharmaceuticals NY LC Recent Development
    Table 76. Glenmark Pharmaceuticals Company Details
    Table 77. Glenmark Pharmaceuticals Business Overview
    Table 78. Glenmark Pharmaceuticals Teriflunomide Product
    Table 79. Glenmark Pharmaceuticals Revenue in Teriflunomide Business (2016-2021) & (US$ Million)
    Table 80. Glenmark Pharmaceuticals Recent Development
    Table 81. Msn Laboratories Private Limited Company Details
    Table 82. Msn Laboratories Private Limited Business Overview
    Table 83. Msn Laboratories Private Limited Teriflunomide Product
    Table 84. Msn Laboratories Private Limited Revenue in Teriflunomide Business (2016-2021) & (US$ Million)
    Table 85. Msn Laboratories Private Limited Recent Development
    Table 86. Research Programs/Design for This Report
    Table 87. Key Data Information from Secondary Sources
    Table 88. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Teriflunomide Market Share by Type: 2020 VS 2027
    Figure 2. Tablets Features
    Figure 3. Powder Features
    Figure 4. Global Teriflunomide Market Share by Application: 2020 VS 2027
    Figure 5. Immunosuppression Case Studies
    Figure 6. Cancer Treatment Case Studies
    Figure 7. Teriflunomide Report Years Considered
    Figure 8. Global Teriflunomide Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 9. Global Teriflunomide Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Teriflunomide Market Share by Regions: 2020 VS 2027
    Figure 11. Global Teriflunomide Market Share by Regions (2022-2027)
    Figure 12. Global Teriflunomide Market Share by Players in 2020
    Figure 13. Global Top Teriflunomide Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Teriflunomide as of 2020
    Figure 14. The Top 10 and 5 Players Market Share by Teriflunomide Revenue in 2020
    Figure 15. Global Teriflunomide Revenue Market Share by Type (2016-2021)
    Figure 16. Global Teriflunomide Revenue Market Share by Type (2022-2027)
    Figure 17. North America Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 18. North America Teriflunomide Market Share by Type (2016-2027)
    Figure 19. North America Teriflunomide Market Share by Application (2016-2027)
    Figure 20. North America Teriflunomide Market Share by Country (2016-2027)
    Figure 21. United States Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. Canada Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Europe Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Teriflunomide Market Share by Type (2016-2027)
    Figure 25. Europe Teriflunomide Market Share by Application (2016-2027)
    Figure 26. Europe Teriflunomide Market Share by Country (2016-2027)
    Figure 27. Germany Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. France Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. U.K. Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Italy Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Russia Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Nordic Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Asia-Pacific Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Teriflunomide Market Share by Type (2016-2027)
    Figure 35. Asia-Pacific Teriflunomide Market Share by Application (2016-2027)
    Figure 36. Asia-Pacific Teriflunomide Market Share by Region (2016-2027)
    Figure 37. China Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Japan Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. South Korea Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Southeast Asia Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. India Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Australia Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Latin America Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Teriflunomide Market Share by Type (2016-2027)
    Figure 45. Latin America Teriflunomide Market Share by Application (2016-2027)
    Figure 46. Latin America Teriflunomide Market Share by Country (2016-2027)
    Figure 47. Mexico Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Brazil Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Middle East & Africa Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Teriflunomide Market Share by Type (2016-2027)
    Figure 51. Middle East & Africa Teriflunomide Market Share by Application (2016-2027)
    Figure 52. Middle East & Africa Teriflunomide Market Share by Country (2016-2027)
    Figure 53. Turkey Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Saudi Arabia Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. UAE Teriflunomide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Sanofi Aventis Revenue Growth Rate in Teriflunomide Business (2016-2021)
    Figure 57. Genzyme Corporation Revenue Growth Rate in Teriflunomide Business (2016-2021)
    Figure 58. Amneal Pharmaceuticals NY LC Revenue Growth Rate in Teriflunomide Business (2016-2021)
    Figure 59. Glenmark Pharmaceuticals Revenue Growth Rate in Teriflunomide Business (2016-2021)
    Figure 60. Msn Laboratories Private Limited Revenue Growth Rate in Teriflunomide Business (2016-2021)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi Aventis
Genzyme Corporation
Amneal Pharmaceuticals NY LC
Glenmark Pharmaceuticals
Msn Laboratories Private Limited
Frequently Asked Questions
Teriflunomide report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Teriflunomide report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Teriflunomide report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports